Clinical Trial Update: Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating durvalumab with chemotherapy followed by sequential radiotherapy in limited stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Beijing Haidian Hospital | Conditions: Limited Stage Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN